CEN BIOTECH INC Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q4 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Cen Biotech Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q4 2020 to Q3 2022.
  • Cen Biotech Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending September 30, 2022 was $0.000.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $0 $0 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 $0 Jun 30, 2022 10-Q 2022-08-22
Q4 2021 $0 $0 Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $0 Sep 30, 2021 10-Q 2021-11-19
Q2 2021 $0 Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $0 Dec 31, 2020 10-Q 2022-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.